You are here: Industry Insights > Zydus Cadila

News List

Zydus Cadila Receives FDA Approval for Cisatracurium Besylate Injection americanpharmaceuticalreview
September 07, 2020
Zydus Cadila has received final approval from the US Food and Drug Administration (FDA) to market Cisatracurium Besylate Injection USP (US RLD: Nimbex ®) in the strength of 20 mg (base)/10 mL (2 mg/mL) Multiple-Dose Vial.
Zydus Cadila gets USFDA nod to market midodrine hydrochloride tablets expresspharma
September 04, 2020
These tablets are indicated to treat patients who have symptoms of low blood pressure when standing, a condition known as orthostatic hypotension.
Zydus Cadila gets US FDA approval for Cisatracurium Besylate Injection expresspharma
September 03, 2020
Zydus Cadila has received final approval from the USFDA to market Cisatracurium Besylate Injection USP (US RLD: Nimbex) in the strength of 20 mg (base)/10 mL (2 mg/mL) multiple-dose vial.
Zydus Cadila launches remdesivir at Rs 2800 per 100 mg vial expresspharma
August 14, 2020
To be sold under brand name Remdac, the API for the drug has been developed and manufactured at the company’s API manufacturing facilities in Gujarat.
Zydus Cadila completes dosing in Phase I clinical trial of ZyCoV-D expresspharma
August 06, 2020
Zydus Cadila announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was found to be safe and well-tolerated in Phase I clinical trial. The company will now commence Phase II clinical trials from August 6, 2020.
Zydus Cadila gets tentative US FDA approval for Carbidopa and Levodopa extended-release capsules expresspharma
August 03, 2020
This medication is used to treat the symptoms of Parkinson’s disease or Parkinson-like conditions.
Zydus Cadila gets US FDA nod for drug trials to treat chemotherapy-induced anemia expresspharma
July 24, 2020
Desidustat is a novel drug which is also currently undergoing phase-III trials for treating anemia in chronic kidney disease patients and phase-II studies for management of COVID-19 patients.
Zydus receives approval from COFEPRIS to conduct clinical trials for COVID-19 treatment therapy expresspharma
July 20, 2020
Zydus had earlier approached the DCGI to investigate the role of Pegylated Interferon alpha-2b for COVID 19 and the clinical trials are now underway.
Zydus Cadila plans to complete trials of COVID-19 vaccine by March expresspharma
July 20, 2020
Early-stage Phase 1 and 2 human trials are likely to be concluded in the next three months.
Zydus Cadila gets US FDA nod to market generic tension headache tablets expresspharma
July 20, 2020
The drug will be manufactured at Nesher Pharma’s manufacturing facility at St Louis in the US.

Previous page 1 2 3 4 5 6 7 8 Next page